Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells

Adjuvant chemotherapy has become the frequently adopted standard therapeutic approach for non-small cell lung cancer (NSCLC). However, the development of multidrug resistance (MDR) is a major obstacle contributing to the failure of chemotherapy. This study aimed to identify genes associated with MDR...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Huaping, Li, Tangying, Chen, Mingjing, Liu, Feng, Wu, Haifeng, Wang, Jie, Chen, Jialiang, Li, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258490/
https://www.ncbi.nlm.nih.gov/pubmed/30505321
http://dx.doi.org/10.1186/s11658-018-0119-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258490/
https://www.ncbi.nlm.nih.gov/pubmed/30505321
http://dx.doi.org/10.1186/s11658-018-0119-8

Ejemplares similares